Sir George Howarth

To ask the Secretary of State for Health and Social Care, what the value of contracts awarded to non-NHS providers was for the provision of clinical services in the (a) 2022-23, (b) 2021-22 and (c) 2020-21 financial years.

To ask the Secretary of State for Health and Social Care, how much was spent on private sector contracts for the provision of clinical services in the most recent financial year for which data is available.

To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Excellence plans to launch a public consultation to take forward the commitment in the 2024 Rare Disease Action Plan for England to review the cri...

To ask the Secretary of State for Health and Social Care, what discussions she has had with the National Institute for Health and Care Excellence in relation to the commitment in the Rare Disease Action Plan for England 2024 to review the criteria for det...

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to consult young people with cancer affected by cancer during the development of the Children and Young People Taskforce.

To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure the (a) experiences and (b) specialist needs of young people with cancer are reflected in the work of the Children and Young People Cancer Taskforce.

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of discontinuing funding for T1DE pilot schemes on the health and well-being of patients living with type 1 diabetes with disordered eating.

To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the potential implications for her policies of public satisfaction with the NHS.

To ask the Secretary of State for Health and Social Care, what the rate of public satisfaction with the NHS was in (a) February 2024 or (b) the most recent month and year that data has been collected.

To ask the Secretary of State for Health and Social Care, whether she (a) has made and (b) plans to make an assessment of the potential merits of funding options to ensure the sustainability of T1DE services beyond the pilot phase.

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential implications for its policies of the cost-benefit analysis of the T1DE pilot schemes carried out by NHS England.

To ask the Secretary of State for Health and Social Care, how many and what proportion of NHS consultants carried out work in the private sector in the most recent financial year for which data is available.

To ask the Minister of State, Foreign, Commonwealth and Development Office, if he will make an assessment of the implications for his policies of the recent arrests of Afghan women and girls for alleged violations of the Islamic dress code.

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce waiting times for (a) diagnosis and (b) treatment for young people with cancer.

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of targeted awareness campaigns for young people on the five main warning signs and symptoms of cancer.

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve awareness of the (a) signs and (b) symptoms of cancer in young people.

To ask the Secretary of State for Health and Social Care, how many and what proportion of patients with type 1 diabetes use real time continuous glucose monitoring to manage their diabetes.

To ask the Secretary of State for Health and Social Care, how many and what proportion of patients with type 1 diabetes use (a) finger-pricking monitoring and (b) continuous monitoring to track their glucose levels.

To ask the Secretary of State for Health and Social Care, what discussions she has had with (a) NICE and (b) NHS England on encouraging the adoption of new treatments for (i) sickle cell disease and (ii) beta-thalassaemia.

To ask the Secretary of State for Health and Social Care, what discussions she has had with the National Institute for Health and Care Excellence on updates in the way that it assesses medicines that reduce health inequalities.